logo
logo
Sign in

Pharmaceutical Excipients Market Revenue, Regional & Country Share, Key Factors, Trends & Analysis, To 2027

avatar
jhon tanison

 

The rise in the number of diseases globally, the development of new drugs, technological advances for formulations ongoing new product launches, and strategic collaboration, awareness among people for better healthcare facilities are key factors contributing to the high CAGR of the Pharmaceutical Excipients market during the forecast period.

Market Size – USD 6.53 Billion in 2019, Market Growth - CAGR of 5.7% Market Trends–  High manufacturing of pharmaceutical drugs

According to the current analysis of Reports and Data, the global Pharmaceutical Excipients Market valued at USD 6.53 billion in 2019 and is expected to reach USD 10.15 billion by the year 2027, at a CAGR of 5.7%. Excipients are the products that do not show any activity of the drug but facilitates the drug delivery process. The increase in the outbreak of pandemic or epidemic diseases across the globe is the primary factor for boosting the growth of the market. The problems associated with instability, poor solubility, and absorption of active pharmaceutical ingredients are driving the demand for pharmaceutical excipients. The development of nanotechnology for the administration of drugs is further boosting the growth of the market. In 2015, the amount of manufacturing of final products of drugs in Japan accounted for 6,820.4 billion yen, the amount of import was 4,022 billion yen. Increasing outbreak of life threatening diseases and increasing incidences of resistance over traditional treatment plan resulting in increasing number of final production are expected to boost the market growth.

North America has obtained remarkable growth in the market due to the awareness among the consumers for better healthcare, government initiatives for research and development of new drugs, clinical trials, and due to better facilities for healthcare in the region. However, the high cost of drug development is the primary restraint to market growth.

Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/2713

The report puts an emphasis on the information regarding the key players with a special focus on their company profile, business overview, recent advancements, product catalog, and strategic business plans. It provides a comprehensive overview of the strategic alliances in the market under taken by the key players such as mergers and acquisitions, joint ventures, collaborations, partnerships, agreements, product launches, brand promotions, and corporate deals, among others.

Key companies operating in the market and profiled in the report include:

Ashland Global Holdings (US), BASF SE (Germany), DuPont (US), Roquette Feres (France), Evonik Industries AG (Germany), Associated British Foods (UK), Archer Daniels Midland Company (US), Lubrizol Corporation (US), Croda International (UK). Innophous Holdings (US), Kerry Group (Ireland), WACKER Chemie AG (Germany), Colorcon (US), DFE Pharma (Germany), JRS Pharma (Germany), and Air Liquide (France)

Request a discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/2713

The Pharmaceutical Excipients market takes into account major geographical locations such as North America, Europe, Asia Pacific, Latin America, and Middle East & Africa to offer key insights into market growth, market size, market share, revenue growth, current and emerging trends, supply and demand ratio, import/export, consumer demand and behavior, and presence of key players in each region. The report offers an in-depth country wise analysis to impart better understanding of the market and its growth prospects.

Segments Covered in the report

Products Outlook (Revenue in Million USD; (2017–2027)

  • Organic Chemicals
    • Oleochemicals
      • Fatty Alcohols
      • Mineral Stearates
      • Glycerin
      • Other Oleochemicals
    • Carbohydrates
      • Sugars
        • Actual Sugars
          • Lactose
          • Sucrose
          • Dextrose (D-Glucose)
        • Sugar Alcohols
          • Mannitol
          • Sorbitol
          • Other Sugar Alcohols
        • Artificial Sweeteners
      • Cellulose
        • Microcrystalline Cellulose
        • Cellulose Ethers
        • CMC and Croscarmellose Sodium
        • Cellulose Esters
      • Starch
        • Modified Starch
        • Dried Starch
        • Converted Starch
      • Petrochemicals
        • Glycols
          • Polyethylene Glycol
          • Propylene Glycol
        • Povidones
        • Mineral Hydrocarbons
          • Petrolatum
          • Mineral Waxes
          • Mineral Oils
        • Acrylic Polymers
        • Other Petrochemicals
      • Proteins
      • Other Organic Chemicals
    • Inorganic Chemicals
      • Calcium Phosphate
      • Metal Oxides
      • Halites
      • Calcium Carbonate
      • Calcium Sulfate
      • Other Inorganic Chemicals
    • Others
      • Pharmaceutical-Grade Water 
      • Mucilage

Functionality Outlook (Revenue in Million USD; (2017–2027)

  • Fillers and Diluents
  • Suspending and Viscosity Agents
  • Coating Agents
  • Binders
  • Flavouring Agents and Sweeteners
  • Disintegrates
  • Colorants
  • Lubricants and Glidants
  • Preservatives
  • Emulsifying Agents
  • Others

Formulations Outlook (Revenue in Million USD; (2017–2027)

  • Oral Formulations
    • Tablets
    • Capsules
      • Hard Gelatin Capsules
      • Soft Gelatin Capsules
    • Liquid Formulations
    • Topical Formulations
    • Parenteral Formulations
    • Others

End Use Outlook (Revenue in Million USD; (2017–2027)

  • Pharmaceutical companies
  • Chemical companies
  • Others

 

Key Regions Analyzed in the Report include:

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • U.K.
    • Italy
    • France
    • BENELUX
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of APAC
  • Latin America
    • Brazil
    • Rest of LATAM
  • Middle East & Africa
    • Saudi Arabia
    • U.A.E.
    • South Africa
    • Rest of MEA

To know more about the report @ https://www.reportsanddata.com/report-detail/pharmaceutical-excipients-market

Furthermore, it consists information about individual segment of the Pharmaceutical Excipients market based on the types and application. The report also offers insights about the key segments expected to register significant revenue growth over the forecast period and primary trends influencing their growth. It also offers CAGR and market share values for each segment to provide clear understanding of demand and trend in the global market.

Further key findings from the report suggest

  • Evonik in the year 2017 had launched a new sterile, and ultra-low-metal content bioresorbable polymers known as RESOMER ZERO it is an ultra-low tin content PLGA poly (lactic-co-glycolic acid) excipient and is the first sterile controlled release (PLGA) excipient in the market. It was designed for the controlled-release parenteral drug formulation.
  • Croda International, in the year 2018 had launched Moonshine Effect Pigments, it is a range of borosilicate-based effect pigments, it is specially designed for personal care products, the quality borosilicate substrate produces the effect exceptional vibrancy, intensity, and color transmission for eye-catching results in cosmetic formulations.
  • JRS Pharma had received an EXCiPACT Certificate from DQS for the production of Microcrystalline Cellulose and Silicified Microcrystalline Cellulose and for Good Distribution Practice for the central logistic warehouse. The certificate justifies that the Micro cellulose is manufactured and distributed according to the EXCiPACT Good Manufacturing Practice (GMP) and Good Distribution Practice (GDP) Certification Standard. The certificate is beneficial for the drug manufacturers to reduce their efforts and costs for performing quality control.
  • Oral formulations in the formulations segment have obtained the largest share due to the rise in demand for formulations like tablets, capsules, and oral solutions and suspensions. It is likely to grow with a CAGR of 5.9% in the forecast period.

Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/2713

Thank you for reading our report. For any specific details on customization of this report, please get in touch with us. We will ensure the report you get is well-suited to your needs.

 Browse More Reports:

Gonorrhea Testing Market

Joint Replacement Market

 

 

 

collect
0
avatar
jhon tanison
guide
Zupyak is the world’s largest content marketing community, with over 400 000 members and 3 million articles. Explore and get your content discovered.
Read more